Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals
- 7 February 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Transgenic Research
- Vol. 16 (2), 147-161
- https://doi.org/10.1007/s11248-007-9074-2
Abstract
Significant advances over the last few years have seen plant-made pharmaceuticals (PMPs) move from the exploratory research phase towards clinical trials, with the first commercial products for human use expected to reach the market by 2009. Europe has yet to witness the commercial application of PMP technology, although at least one product has begun phase II clinical trials with others following close behind. These emerging products are set to challenge the complex and overlapping regulations that currently govern GM plants and ‘conventional’ pharmaceutical production. The areas of responsibility are being mapped out between the different EU regulatory agencies, with specific guidelines currently being drawn up for the regulation of PMPs. This article discusses issues surrounding the development of robust risk-assessment and risk-management practices based on health and environmental impact, while working with EU regulatory authorities to ensure appropriate regulatory oversight.Keywords
This publication has 51 references indexed in Scilit:
- Molecular farming for new drugs and vaccinesEMBO Reports, 2005
- Production and glycosylation of plant‐made pharmaceuticals: the antibodies as a challengePlant Biotechnology Journal, 2004
- Molecular farming in plants: host systems and expression technologyTrends in Biotechnology, 2003
- The production of recombinant pharmaceutical proteins in plantsNature Reviews Genetics, 2003
- Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plantsBiochemical and Biophysical Research Communications, 2003
- Codex guidelines for GM foods include the analysis of unintended effectsNature Biotechnology, 2003
- Tougher rules aim to prevent gene flow into cropsNature, 2003
- EXECUTIVE SUMMARYJournal of Toxicology and Environmental Health, Part A, 2001
- Production of Recombinant Proteins in Tobacco Guttation FluidPlant Physiology, 2000
- Natural and Controlled Crossing in Safflower, Carthamus tinctorius L.1Agronomy Journal, 1950